Gene Query: CITED4

Dataset Description Geneva Score
RNA sequencing of GlyH-101-treated MCF-7 cell line 88.44
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 71.39
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 71.39
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 53.92
Transcriptome analysis in Neobractatin treated cells 49.95
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 40.95
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 40.95
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 38.62
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 37.1
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 34.28
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 32.92
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 32.28
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 32.19
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 31.52
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 30.88
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 30.61
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 30.0
The pioneer factor CEBPA modulates vitamin D signaling 30.0
Regulation of highly expressed hCINAP on translatome 28.57
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 28.55
Irf9 function in immunity in mouse 28.05
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 28.05
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 27.85
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 27.85
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 26.92
TGF-β promotes genomic instability after loss of RUNX3 26.44
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 26.15
CHD1 regulates cell fate determination by activation of differentiation-induced genes 26.14
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 26.03
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 25.19
ARS2 is a general suppressor of pervasive transcription [RNAseq] 24.7
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 22.67
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 21.61
Single-nucleotide-resolution mapping of HBV promoters using CAGE 19.89
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 19.62
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 19.16
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 18.22
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 18.11
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 17.65
Uridylation by TUT4 and TUT7 marks mRNA for degradation 17.28
BAF controls genome accessibility 17.07
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 17.05
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 16.59
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 16.22
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 15.85
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 15.85
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 15.83
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 15.6
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 15.6
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 15.2
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 13.92
Effect of drugs on transcriptomic profiles 13.58
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 13.32
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 13.18
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 13.15
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 12.89
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 12.89
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 12.74
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 12.65
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 12.57
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 12.35
Zone dependent distinctive gene expression profile of the normal human liver tissue 12.3
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 11.95
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 11.61
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 11.57
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 11.57
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 11.36
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 11.36
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 11.18
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 11.08
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 11.06
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 11.02
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 10.97
EWSR1 influences alternative splicing through direct and indirect mechanisms 10.93
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 10.77
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 10.52
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 10.52
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 10.13
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 10.13
Loss of endometrial plasticity in recurrent pregnancy loss 9.7
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 9.7
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 9.47
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 9.47
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 9.13
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 9.01
Nrf2 regulated genes in A549 cells 8.95
Identification of Nrf2 regulated genes by RNA sequencing 8.95
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 8.92
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 8.85
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 8.83
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 8.51
Sensing self and nonself circular RNAs 8.31
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 8.31
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 8.29
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 8.25
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 8.24
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 8.14
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 7.95
Transcription elongation regulates genome 3D structure 7.91
IDH3a KO RNA-seq 7.89
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 7.73
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 7.73
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 7.7
IL-33 activates tumor stroma to promote intestinal polyposis 7.58
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 7.55
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 7.43
U1 snRNP telescripting regulates size-function stratified human genome 7.41
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 7.34
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 7.33
Transcriptional effect of ETV1 knockdown in melanoma cells 7.31
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 7.28
Gene expression analysis of the impact of TDP-43 knockout in human cells. 7.15
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 7.14
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 7.02
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 7.0
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 6.87
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 6.83
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 6.83
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 6.82
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 6.76
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 6.74
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 6.59
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 6.52
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 6.5
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 6.42
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 6.37
A practical evaluation of alignment algorithms for RNA variant calling analysis 6.36
RNA-seq analysis and shRNA screen of breast cancer 6.3
RNA-seq analysis of breast cancer 6.3
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 6.21
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 6.19
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 6.15
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 6.11
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 6.11
RNA-seq of tumor cells following angiopellosis extravasation 6.06
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 6.05
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 6.02
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 6.02
ADAR1-editing of cellular and measles virus-derived duplex RNA 6.0
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 6.0
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 5.95
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 5.93
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 5.93
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 5.87
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 5.84
m6A-dependent regulation of messenger RNA stability 5.64
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 5.58
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 5.54
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 5.53
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 5.53
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 5.48
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 5.43
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 5.39
Patient-derived luminal breast cancer xenografts with progestins 5.38
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 5.38
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 5.35
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 5.35
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 5.34
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 5.34
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 5.34
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 5.29
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 5.29
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 5.27
Spliceosomal disruption of the non-canonical BAF complex in cancer 5.26
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 5.21
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 5.14
Neonatal and adult human testis defined at the single-cell level 5.14
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 5.12
Genome wide expression change in LCC2 and MCF-7 cells 5.07
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 4.99
Identification of transcription start sites for human A549 cell line using ReCappable-seq 4.94
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 4.93
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 4.93
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 4.92
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 4.9
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 4.9
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 4.89
Effect of ILF3 on translation during homeostasis and the antiviral response 4.86
mRNA recovered upon RNF219 IP. [RNA-IP] 4.84
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 4.83
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 4.8
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 4.78
Dermal endothelial cells of type 2 diabetic patients 4.76
A prostate cancer chromatin interaction map 4.71
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 4.71
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 4.64
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 4.63
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 4.6
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 4.55
NR2F2 study 4.53
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 4.53
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 4.48
Exploring ILF2 regulatory genes by next-generation sequencing 4.41
Role of COP1 on MAP kinase transcriptional output in melanoma 4.36
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 4.36
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 4.36
Splicing and epigenetic factors jointly regulate epidermal differentiation 4.34
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 4.31
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 4.27
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 4.2
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 4.1
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 4.1
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 4.09
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 4.06
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 4.03
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.01
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 4.01
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 4.01
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 4.0
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 3.98
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 3.97
A549 cell transcriptome responses to infection with H7N9 influenza virus 3.93
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 3.91
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 3.9
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 3.88
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 3.83
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 3.8
Microprocessor mediates transcription termination in long noncoding microRNA genes 3.8
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 3.78
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 3.77
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 3.77
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 3.72
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 3.63
ARID1A and ARID1B loss in HCT116 and TOV21G cells 3.6
Gene Expression Profiling of SPOP Knocked Down Cell 3.6
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 3.57
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 3.53
RNAseq of cell lines with knocked in ESR1 mutations 3.49
mRNA-sequencing of breast cancer subtypes and normal tissue 3.47
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 3.45
Genome wide expression change by RNF168 knocking down in NEC cells 3.45
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 3.44
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 3.43
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 3.42
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 3.41
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 3.41
Transcriptome profiling of Normal and Cancerous Prostate Cells 3.4
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 3.38
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 3.35
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 3.35
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 3.35
Genome wide expression change by RNF168 knocking down in MCF-7 cells 3.32
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 3.31
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 3.29
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 3.29
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 3.29
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 3.27
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 3.26
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 3.24
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 3.23
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 3.23
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 3.21
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 3.21
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 3.15
hnRNP C is a key regulator of protein synthesis in mitosis 3.09
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 3.09
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 3.09
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 3.08
Molecular analysis of renal cell carcinoma with unclassfied histology 3.08
RNA sequencing of mechanically strained NHEKs and control NHEKs 3.07
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 3.07
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 3.06
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 3.06
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 3.06
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 3.06
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 3.05
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 3.05
RNA seq comparison between scrambled and shGRP78 cells 3.04
Zika virus infection reprograms global transcription of host cells to allow sustained infection 3.03
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 3.01
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 3.01
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 2.99
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 2.98
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 2.92
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 2.92
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 2.92
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 2.91
Effect of nuclear IL-33 on gene expression 2.9
quanTIseq: quantifying immune contexture of human tumors 2.9
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 2.88
RNA-sequencing in immortalized human mammary epithelial cells 2.86
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 2.86
Hepatocyte maturation 2.86
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 2.82
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 2.79
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 2.78
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 2.75
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 2.75
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 2.74
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 2.73
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 2.7
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 2.68
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 2.65
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 2.64
MAIT cell RNA sequencing 2.62
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 2.61
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 2.6
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 2.59
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.58
RNA seq analysis of human Fetal and adult derived Enterospheres 2.58
G-quadruplex structures mark human regulatory chromatin 2.56
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 2.56
Genome-wide analysis of Dengue virus 2 infected cells 2.55
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 2.53
RNA m5C Methylation in breast cancer using MeRIP-Seq 2.52
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 2.51
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 2.49
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 2.49
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 2.46
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 2.41
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 2.38
Fbxo32 mediated gene expression program underlies EMT and metastasis 2.38
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 2.37
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 2.35
RNA-Seq of PRMT1 overexpression ECA109 cells 2.34
Copper Regulation of HIF-1 Transcription Activity 2.3
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.3
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 2.3
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 2.3
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.29
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 2.29
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 2.29
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 2.27
Leucegene: AML sequencing (part 6) 2.25
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 2.21
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 2.2
High-Throughput Kinetic Analysis of Fractional Killing 2.18
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 2.17
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 2.16
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 2.15
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 2.14
Enhancer activation during EGF response 2.13
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 2.12
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.11
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 2.08
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 2.04
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 2.02
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 2.0
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.99
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 1.98
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 1.95
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 1.89
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 1.88
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 1.88
Small-molecule targeting of brachyury transcription factor addiction in chordoma 1.87
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 1.84
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 1.82
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.81
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.81
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 1.8
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 1.79
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 1.79
Gene expression analysis of breast cancer cell-lines 1.78
Gene expression and genome-wide location analysis of breast cancer cell-lines 1.78
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 1.75
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 1.75
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 1.73
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 1.72
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 1.7
Hepatic transcriptome of pediatric hepatoblastoma. 1.7
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 1.69
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 1.69
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 1.69
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 1.68
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 1.68
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 1.67
Selective expression of long non-coding RNAs in a breast cancer cell progression model 1.67
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 1.66
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 1.62
Transcriptomic analyssis following EHMT1/2 inhibition 1.61
Direct Isolation and Characterization of Human Nephron Progenitors. 1.61
Proliferation-correlated expression 1.59
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 1.58
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 1.55
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 1.55
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 1.49
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.49
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.48
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 1.48
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 1.41
CSL 1.36
CSL RNA-Seq on HKC and SCC cell lines 1.36
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 1.36
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 1.34
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 1.34
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.33
H1609088 Human RNA-Sequencing 1.33
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 1.33
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 1.33
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 1.31
Regulatory network controlling tumor-promoting inflammation in human cancers 1.31
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 1.27
Endometrial transcriptome and PGR cistrome in cycling fertile women 1.26
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 1.26
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 1.25
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 1.18
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 1.18
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 1.16
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 1.13
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 1.13
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 1.09
TAF1 is critical for AE driven leukemogenesis 1.07
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 1.07
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.07
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 1.06
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 1.05
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 1.04
Transcriptome analysis of kidney organoids 1.02
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 1.0
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 1.0
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 0.98
Positively selected enhancer elements endow tumor cells with metastatic competence 0.97
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 0.96
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 0.96
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 0.95
Single-Cell Genotyping of Transcriptomes 0.94
RNA-seq of Single-Cell Genotyping of Transcriptomes 0.94
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 0.93
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 0.89
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.88
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.86
Genetic-to-epigenetic Therapy for Pancreatic Cancer 0.84
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.84
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.83
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.82
Human islets of varying quality: the good, the (not so) bad and the ugly 0.8
MicroRNA-125a-5p overexpression in human macrophages 0.77
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.76
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 0.74
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 0.71
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 0.71
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 0.7
RNA sequencing of human pancreatic cancer cell lines 0.69
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.67
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 0.65
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 0.65
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 0.64
Retinoic acid suppresses MYB in adenoid cystic carcinoma 0.64
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 0.64
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 0.6
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 0.6
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 0.59
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.57
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 0.56
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 0.56
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.54
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.54
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.54
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.53
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 0.53
Conservative alteration of chromosomal expression pattern across human solid tumor types 0.53
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.5
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.49
Fusion discovery in breast cancer cell line 0.48
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 0.47
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 0.46
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 0.46
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.45
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.43
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 0.41
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 0.41
Gene expression of thyroid cancer cell lines 0.4
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 0.4
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.39
Tpl-2 small molecule project 0.39
Tpl-2 and MEK small molecule inhibitors 0.39
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  0.39
Transcriptome-wide modulation of splicing by the exon junction complex 0.37
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.37
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.35
The circadian transcriptional landscape in primary human mammary epithelial cells 0.35
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 0.34
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 0.34
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.33
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.31
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 0.28
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.28
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 0.28
Discovering human diabetes-risk gene function with genetics and physiological assays 0.25
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.23
Preclinical model of obesity and ER-positive breast cancer 0.23
SUV420H2 knockdown in PANC-1 0.19
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.18
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.16
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.14
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 0.13
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.13
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.12
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.12
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.12
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.12
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 0.09
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 0.08
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 0.08
Single cell transcriptome of peritoneal cells 0.08
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 0.06
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.06
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.05
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.04
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation